desmopressin acetate 0.004 MG/ML Injectable Solution [DDAVP]
- RxCUI
- 849503
- RxNorm name
- desmopressin acetate 0.004 MG/ML Injectable Solution [DDAVP]
- Display name
- desmopressin acetate 0.004 MG/ML Injectable Solution [DDAVP]
- Full name
- desmopressin acetate 0.004 MG/ML Injectable Solution [DDAVP]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:01
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DDAVP | DESMOPRESSIN ACETATE | Ferring Pharmaceuticals Inc. | 651f6fee-a2c7-431b-8d5d-58b156c72244 | 2022-09-28 | Boxed warning, Warnings, Adverse reactions | 849503 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 651f6fee-a2c7-431b-8d5d-58b156c72244 | DDAVP 4 MCG/ML Injectable Solution [PSN] · desmopressin acetate 0.004 MG/ML Injectable Solution [DDAVP] [SBD] · DDAVP 0.004 MG/ML Injectable Solution [SY] · DDAVP 4 MCG/ML Injectable Solution [SY] | 4 | 15 | These highlights do not include all the information needed to use DDAVP Injection® safely and effectively. See full prescribing information for DDAVP Injection. DDAVP (desmopressin acetate) injection, for intravenous or subcutaneous use Initial U.S. Approval: 1978 | 20220928 |